|
|
Voyager Therapeutics Inc (VYGR) |
|
|
|
Voyager Therapeutics Inc 's Yearly EPS from Cont. Operations Growth 5 Years |
|
Select the Comparisons :
|
|
Select the Ratio:
|
Annual EPS from Cont. Operations Annual Growth Rates Y/Y▼
|
Annual EPS from Cont. Operations Annual Growth Rates Y/Y▼
|
VYGR Annual EPS from Cont. Operations Growth |
2023
|
2022
|
2021
|
2020
|
2019
|
Y / Y Annual EPS from Cont. Operations Change |
- |
- |
- |
- |
- |
Annual EPS from Cont. Operations (in $) |
$3.08 |
$-1.21 |
$-1.89 |
$0.99 |
$-1.21 |
Annual EPS from Cont. Operations Growth
Comment |
In the fiscal year ended 2023, company achieved Annual EPS from Cont. Operations of $3.08 compare to EPS loss from Cont. Operations of $-1.21 realized a year before.
Voyager Therapeutics Inc Annual Income Statement
|
You need to upgrade your Flash Player
|
Companies with similar 2023 Annual EPS from Cont. Operations within Healthcare Sector | Y/Y EPS from Cont. Operations Growth % | 2023 Annual EPS from Cont. Operations | Moderna Inc | | | |